Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase

By Nivens Michael   Felder Takita   Galloway Amanda   Pena Maria   Pouliot Jeffery   Spencer H.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Editorial [ DNA Repair as a Target for Anti-Cancer Therapy Guest Editor: Robert M. Brosh Jr. ]

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 350-350

Bentham Science Publishers

Access to resources Recommend Favorite

The Endothelin Receptor: A Novel Target for Anticancer Therapy

By Pirtskhalaishvili G.   Nelson J.B.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite

Activated vitronectin as a target for anticancer therapy with human antibodies

By Bloemendal Haiko   Boer Hetty   Koop Elianne   Dongen Alice   Goldschmeding Roel   Landman Wil   Logtenberg Ton   Gebbink Martijn   Voest Emile  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

Protein Phosphatase 2A as a Potential Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 38-46

Bentham Science Publishers

Access to resources Recommend Favorite